MedPath
FDA Product

Etravirine

Product approved by U.S. Food and Drug Administration (US)

Basic Information

Etravirine

10147-0570

Regulatory Information

10147-0570

NDA022187

C73594

March 26, 2025

USA

These highlights do not include all the information needed to use Etravirine safely and effectively. See full prescribing information for Etravirine. Etravirine tablets, for oral use Initial U.S. Approval: 2008

HUMAN PRESCRIPTION DRUG LABEL

2

Company Information

178220385

Active Ingredients

SILICON DIOXIDE

Code: ETJ7Z6XBU4

Class Code: IACT

MICROCRYSTALLINE CELLULOSE

Code: OP1R32D61U

Class Code: IACT

CROSCARMELLOSE SODIUM

Code: M28OL1HH48

Class Code: IACT

HYPROMELLOSE, UNSPECIFIED

Code: 3NXW29V3WO

Class Code: IACT

LACTOSE MONOHYDRATE

Code: EWQ57Q8I5X

Class Code: IACT

MAGNESIUM STEARATE

Code: 70097M6I30

Class Code: IACT

ETRAVIRINE

Quantity: 100 mg in 1 1

Code: 0C50HW4FO1

Class Code: ACTIB

Active Moieties

ETRAVIRINE

Code: 0C50HW4FO1

© Copyright 2025. All Rights Reserved by MedPath